Search Result

Results for "

MYOS

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Amyloid-β (1) Antibiotic (1) Autophagy (1) Bacterial (1) Biochemical Assay Reagents (28) Calcium Channel (6) Drug Derivative (2) Endogenous Metabolite (5) Fungal (1) HIF/HIF Prolyl-Hydroxylase (2) Isotope-Labeled Compounds (9) Liposome (1) Microtubule/Tubulin (1) Myosin (2) Reference Standards (3) Small Interfering RNA (siRNA) (33) TGF-β Receptor (2)
By Research Areas:	Cancer (5) Cardiovascular Disease (4) Infection (1) Metabolic Disease (8) Neurological Disease (4)
Oligonucleotides:	Rat Pre-designed siRNA Sets (4) Mouse Pre-designed siRNA Sets (4) Phospholipids (7) Human Pre-designed siRNA Sets (25) siRNAs (33)

Inhibitors & Agonists

Biochemical Assay Reagents

Inhibitory Antibodies

Natural
Products

Isotope-Labeled Compounds

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-141510

myo-Inositol trispyrophosphate hexasodium ITPP hexasodium	HIF/HIF Prolyl-Hydroxylase	Cardiovascular Disease Cancer
myo-Inositol trispyrophosphate (ITPP) hexasodium is a salt form of inositol triphosphate (ITPP). myo-Inositol trispyrophosphate (ITPP) hexasodium is a membrane-permeant hemoglobin allosteric regulator. myo-Inositol trispyrophosphate (ITPP) hexasodium enhances the oxygen release capacity of red blood cells by reducing the affinity of hemoglobin to oxygen. myo-Inositol trispyrophosphate (ITPP) hexasodium can be used in the study of cardiovascular disease and cancer .

HY-141510A

myo-Inositol trispyrophosphate hexa-triethylamine ITPP hexa-triethylamine	Biochemical Assay Reagents HIF/HIF Prolyl-Hydroxylase	Cardiovascular Disease Cancer
myo-Inositol trispyrophosphate (ITPP) hexa-triethylamine is a salt form of inositol triphosphate (ITPP). myo-Inositol trispyrophosphate hexa-triethylamine is a membrane-permeant hemoglobin allosteric regulator. myo-Inositol trispyrophosphate hexa-triethylamine enhances the oxygen release capacity of red blood cells by reducing the affinity of hemoglobin to oxygen. myo-Inositol trispyrophosphate hexa-triethylamine can be used in the study of cardiovascular disease and cancer .

HY-RS05604

GOSR2 Human Pre-designed siRNA Set A Bos1; EPM6; GS27; MYOS	Small Interfering RNA (siRNA)	Others
GOSR2 Human Pre-designed siRNA Set A contains three designed siRNAs for GOSR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GOSR2 Human Pre-designed siRNA Set A GOSR2 Human Pre-designed siRNA Set A

HY-146949S

*D-Myo-phosphatidylinositol diC16-d5*	Isotope-Labeled Compounds	Others
D-Myo-phosphatidylinositol diC16-d₅ is deuterium labeled D-Myo-phosphatidylinositol diC16.

HY-146947S

*D-Myo-phosphatidylinositol 4-phosphate diC16-d5*	Isotope-Labeled Compounds	Others
D-Myo-phosphatidylinositol 4-phosphate diC16-d₅ is deuterium labeled D-Myo-phosphatidylinositol 4-phosphate diC16.

HY-RS08952

MYO9A Human Pre-designed siRNA Set A CMS24	Small Interfering RNA (siRNA)	Others
MYO9A Human Pre-designed siRNA Set A contains three designed siRNAs for MYO9A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MYO9A Human Pre-designed siRNA Set A MYO9A Human Pre-designed siRNA Set A

HY-RS08946

MYO5A Human Pre-designed siRNA Set A GS1; MYO5; MYH12; MYR12	Small Interfering RNA (siRNA)	Others
MYO5A Human Pre-designed siRNA Set A contains three designed siRNAs for MYO5A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MYO5A Human Pre-designed siRNA Set A MYO5A Human Pre-designed siRNA Set A

HY-RS08944

MYO3A Human Pre-designed siRNA Set A DFNA90; DFNB30	Small Interfering RNA (siRNA)	Others
MYO3A Human Pre-designed siRNA Set A contains three designed siRNAs for MYO3A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MYO3A Human Pre-designed siRNA Set A MYO3A Human Pre-designed siRNA Set A

HY-RS29177

Myo3a Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Myo3a Rat Pre-designed siRNA Set A contains three designed siRNAs for Myo3a gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Myo3a Rat Pre-designed siRNA Set A Myo3a Rat Pre-designed siRNA Set A

HY-RS08950

MYO7A Human Pre-designed siRNA Set A DFNB2; MYU7A; NSRD2; USH1B; DFNA11; MYOVIIA	Small Interfering RNA (siRNA)	Others
MYO7A Human Pre-designed siRNA Set A contains three designed siRNAs for MYO7A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MYO7A Human Pre-designed siRNA Set A MYO7A Human Pre-designed siRNA Set A

HY-RS08931

MYO15A Human Pre-designed siRNA Set A DFNB3; MYO15	Small Interfering RNA (siRNA)	Others
MYO15A Human Pre-designed siRNA Set A contains three designed siRNAs for MYO15A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MYO15A Human Pre-designed siRNA Set A MYO15A Human Pre-designed siRNA Set A

HY-RS08933

MYO16 Human Pre-designed siRNA Set A MYR8; MYAP3; NYAP3; Myo16b; PPP1R107	Small Interfering RNA (siRNA)	Others
MYO16 Human Pre-designed siRNA Set A contains three designed siRNAs for MYO16 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MYO16 Human Pre-designed siRNA Set A MYO16 Human Pre-designed siRNA Set A

HY-RS08937

MYO1A Human Pre-designed siRNA Set A BBMI; MIHC; MYHL; DFNA48; DIAR15	Small Interfering RNA (siRNA)	Others
MYO1A Human Pre-designed siRNA Set A contains three designed siRNAs for MYO1A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MYO1A Human Pre-designed siRNA Set A MYO1A Human Pre-designed siRNA Set A

HY-RS08949

MYO6 Human Pre-designed siRNA Set A DFNA22; DFNB37	Small Interfering RNA (siRNA)	Others
MYO6 Human Pre-designed siRNA Set A contains three designed siRNAs for MYO6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MYO6 Human Pre-designed siRNA Set A MYO6 Human Pre-designed siRNA Set A

HY-RS22663

Myo3a Mouse Pre-designed siRNA Set A 9030416P08Rik	Small Interfering RNA (siRNA)	Others
Myo3a Mouse Pre-designed siRNA Set A contains three designed siRNAs for Myo3a gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Myo3a Mouse Pre-designed siRNA Set A Myo3a Mouse Pre-designed siRNA Set A

HY-RS08930

MYO10 Human Pre-designed siRNA Set A MyoX	Small Interfering RNA (siRNA)	Others
MYO10 Human Pre-designed siRNA Set A contains three designed siRNAs for MYO10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MYO10 Human Pre-designed siRNA Set A MYO10 Human Pre-designed siRNA Set A

HY-RS08936

MYO19 Human Pre-designed siRNA Set A MYOHD1	Small Interfering RNA (siRNA)	Others
MYO19 Human Pre-designed siRNA Set A contains three designed siRNAs for MYO19 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MYO19 Human Pre-designed siRNA Set A MYO19 Human Pre-designed siRNA Set A

HY-RS08934

MYO18A Human Pre-designed siRNA Set A MAJN; TIAF1; MYSPDZ; SPR210; SP-R210	Small Interfering RNA (siRNA)	Others
MYO18A Human Pre-designed siRNA Set A contains three designed siRNAs for MYO18A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MYO18A Human Pre-designed siRNA Set A MYO18A Human Pre-designed siRNA Set A

HY-146948S

*D-Myo-phosphatidylinositol 4,5-bisphosphate diC16-d5*	Isotope-Labeled Compounds	Others
D-Myo-phosphatidylinositol 4,5-bisphosphate diC16-d₅ is deuterium labeled D-Myo-phosphatidylinositol 4,5-bisphosphate diC16.

HY-167287

myo-Inositol,tetraphosphate,pentaammonium salt	Biochemical Assay Reagents	Others
myo-Inositol,tetraphosphate,pentaammonium salt is a biochemical reagent.

HY-RS22664

Myo3b Mouse Pre-designed siRNA Set A A430065P19Rik	Small Interfering RNA (siRNA)	Others
Myo3b Mouse Pre-designed siRNA Set A contains three designed siRNAs for Myo3b gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Myo3b Mouse Pre-designed siRNA Set A Myo3b Mouse Pre-designed siRNA Set A

HY-RS21659

Myo1c Mouse Pre-designed siRNA Set A NMI; MMIb; myr2; MYO1E; mm1beta	Small Interfering RNA (siRNA)	Others
Myo1c Mouse Pre-designed siRNA Set A contains three designed siRNAs for Myo1c gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Myo1c Mouse Pre-designed siRNA Set A Myo1c Mouse Pre-designed siRNA Set A

HY-RS28177

Myo1c Rat Pre-designed siRNA Set A MMI-beta; MMIb; Myr2	Small Interfering RNA (siRNA)	Others
Myo1c Rat Pre-designed siRNA Set A contains three designed siRNAs for Myo1c gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Myo1c Rat Pre-designed siRNA Set A Myo1c Rat Pre-designed siRNA Set A

HY-RS08940

MYO1D Human Pre-designed siRNA Set A myr4; PPP1R108	Small Interfering RNA (siRNA)	Others
MYO1D Human Pre-designed siRNA Set A contains three designed siRNAs for MYO1D gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MYO1D Human Pre-designed siRNA Set A MYO1D Human Pre-designed siRNA Set A

HY-RS08945

MYO3B Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
MYO3B Human Pre-designed siRNA Set A contains three designed siRNAs for MYO3B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MYO3B Human Pre-designed siRNA Set A MYO3B Human Pre-designed siRNA Set A

HY-RS22665

Myo9b Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Myo9b Mouse Pre-designed siRNA Set A contains three designed siRNAs for Myo9b gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Myo9b Mouse Pre-designed siRNA Set A Myo9b Mouse Pre-designed siRNA Set A

HY-RS08932

MYO15B Human Pre-designed siRNA Set A MYO15BP	Small Interfering RNA (siRNA)	Others
MYO15B Human Pre-designed siRNA Set A contains three designed siRNAs for MYO15B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MYO15B Human Pre-designed siRNA Set A MYO15B Human Pre-designed siRNA Set A

HY-RS08939

MYO1C Human Pre-designed siRNA Set A NMI; MMIb; myr2; MyoIC; MMI-beta	Small Interfering RNA (siRNA)	Others
MYO1C Human Pre-designed siRNA Set A contains three designed siRNAs for MYO1C gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MYO1C Human Pre-designed siRNA Set A MYO1C Human Pre-designed siRNA Set A

HY-RS08943

MYO1G Human Pre-designed siRNA Set A HA2; MHAG; HLA-HA2	Small Interfering RNA (siRNA)	Others
MYO1G Human Pre-designed siRNA Set A contains three designed siRNAs for MYO1G gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MYO1G Human Pre-designed siRNA Set A MYO1G Human Pre-designed siRNA Set A

HY-RS08948

MYO5C Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
MYO5C Human Pre-designed siRNA Set A contains three designed siRNAs for MYO5C gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MYO5C Human Pre-designed siRNA Set A MYO5C Human Pre-designed siRNA Set A

HY-RS08953

MYO9B Human Pre-designed siRNA Set A MYR5; CELIAC4	Small Interfering RNA (siRNA)	Others
MYO9B Human Pre-designed siRNA Set A contains three designed siRNAs for MYO9B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MYO9B Human Pre-designed siRNA Set A MYO9B Human Pre-designed siRNA Set A

HY-RS08935

MYO18B Human Pre-designed siRNA Set A KFS4	Small Interfering RNA (siRNA)	Others
MYO18B Human Pre-designed siRNA Set A contains three designed siRNAs for MYO18B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MYO18B Human Pre-designed siRNA Set A MYO18B Human Pre-designed siRNA Set A

HY-RS08951

MYO7B Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
MYO7B Human Pre-designed siRNA Set A contains three designed siRNAs for MYO7B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MYO7B Human Pre-designed siRNA Set A MYO7B Human Pre-designed siRNA Set A

HY-RS08942

MYO1F Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
MYO1F Human Pre-designed siRNA Set A contains three designed siRNAs for MYO1F gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MYO1F Human Pre-designed siRNA Set A MYO1F Human Pre-designed siRNA Set A

HY-RS08938

MYO1B Human Pre-designed siRNA Set A MMIa; myr1; MYH-1c; MMI-alpha	Small Interfering RNA (siRNA)	Others
MYO1B Human Pre-designed siRNA Set A contains three designed siRNAs for MYO1B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MYO1B Human Pre-designed siRNA Set A MYO1B Human Pre-designed siRNA Set A

HY-RS08941

MYO1E Human Pre-designed siRNA Set A FSGS6; MYO1C; HuncM-IC	Small Interfering RNA (siRNA)	Others
MYO1E Human Pre-designed siRNA Set A contains three designed siRNAs for MYO1E gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MYO1E Human Pre-designed siRNA Set A MYO1E Human Pre-designed siRNA Set A

HY-RS29179

Myo9b Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Myo9b Rat Pre-designed siRNA Set A contains three designed siRNAs for Myo9b gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Myo9b Rat Pre-designed siRNA Set A Myo9b Rat Pre-designed siRNA Set A

HY-RS08947

MYO5B Human Pre-designed siRNA Set A DIAR2; MVID1; PFIC10	Small Interfering RNA (siRNA)	Others
MYO5B Human Pre-designed siRNA Set A contains three designed siRNAs for MYO5B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MYO5B Human Pre-designed siRNA Set A MYO5B Human Pre-designed siRNA Set A

HY-RS29178

Myo3b Rat Pre-designed siRNA Set A RGD1560313	Small Interfering RNA (siRNA)	Others
Myo3b Rat Pre-designed siRNA Set A contains three designed siRNAs for Myo3b gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Myo3b Rat Pre-designed siRNA Set A Myo3b Rat Pre-designed siRNA Set A

HY-146946S

*D-Myo-phosphatidylinositol 3,4,5-trisphosphate diC16-d5*	Isotope-Labeled Compounds	Others
D-Myo-phosphatidylinositol 3,4,5-trisphosphate diC16-d₅ is deuterium labeled D-Myo-phosphatidylinositol 3,4,5-trisphosphate diC16.

HY-N2421

Sequoyitol 1 Publications Verification 5-O-Methyl-myo-inositol	Others	Metabolic Disease
Sequoyitol (5-O-Methyl-myo-inositol) is isolated from plants. Sequoyitol (5-O-Methyl-myo-inositol) decreases blood glucose, improves glucose intolerance, and is used to treat diabetes .

HY-163966

Decarboxyl ofloxacin	Biochemical Assay Reagents	Others
(±)-myo-Inositol-1-phosphate is a biochemical assay reagent.

HY-W403046

*D-myo-Inositol-4-phosphate ammonium*	Biochemical Assay Reagents	Others
D-myo-Inositol-4-phosphate (ammonium) is a biochemical reagent.

HY-W794205

*D-myo-Inositol 4-monophosphate biscyclohexylammonium*	Biochemical Assay Reagents	Others
D-myo-Inositol 4-monophosphate (biscyclohexylammonium) is a biochemical reagent.

HY-W793477

*D-myo-Inositol 1-monophosphate dipotassium*	Biochemical Assay Reagents
D-myo-Inositol 1-monophosphate (dipotassium) is a biochemical reagent .

HY-103642A

*D-myo-Inositol-1,4,5-triphosphate trisodium* 1 Publications Verification Inositol 1,4,5-trisphosphate trisodium; Ins(1,4,5)-P3 trisodium	Calcium Channel	Metabolic Disease
D-myo-Inositol-1,4,5-triphosphate sodium salt is the trisodium salt of D-myo-Inositol 1,4,5-trisphosphate (1,4,5-IP3), which is a second messenger that stimulates the discharge of calcium from the endoplasmic reticulum.

HY-103642

*D-myo-Inositol 1,4,5-trisphosphate hexapotassium salt* Inositol 1,4,5-trisphosphate hexapotassium salt; Ins(1,4,5)-P3 hexapotassium salt	Calcium Channel	Metabolic Disease
D-myo-Inositol 1,4,5-trisphosphate hexapotassium salt is the hexapotassium salt of D-myo-Inositol 1,4,5-trisphosphate (1,4,5-IP3), which is a second messenger that stimulates the discharge of calcium from the endoplasmic reticulum.

HY-W790474

*D-myo-Inositol 1,3,4-tris-phosphate*	Biochemical Assay Reagents	Others
D-myo-Inositol 1,3,4-tris-phosphate is a biochemical assay reagent.

HY-W741523

*1,2:4,5-Di-O-cyclohexylidene-D-myo-inositol*	Biochemical Assay Reagents	Others
1,2:4,5-Di-O-cyclohexylidene-D-myo-inositol is a biochemical assay reagent.

HY-167241

*D-myo-Inositol,1,5,6-tris(dihydrogen phosphate),ammonium salt*	Biochemical Assay Reagents	Others
D-myo-Inositol,1,5,6-tris(dihydrogen phosphate),ammonium salt is a biochemical reagent.

Cat. No.	Product Name	Type

HY-167287

myo-Inositol,tetraphosphate,pentaammonium salt	Cell Assay Reagents
myo-Inositol,tetraphosphate,pentaammonium salt is a biochemical reagent.

HY-163966

Decarboxyl ofloxacin	Chelators
(±)-myo-Inositol-1-phosphate is a biochemical assay reagent.

HY-W403046

*D-myo-Inositol-4-phosphate ammonium*	Cell Assay Reagents
D-myo-Inositol-4-phosphate (ammonium) is a biochemical reagent.

HY-W794205

*D-myo-Inositol 4-monophosphate biscyclohexylammonium*	Cell Assay Reagents
D-myo-Inositol 4-monophosphate (biscyclohexylammonium) is a biochemical reagent.

HY-W793477

*D-myo-Inositol 1-monophosphate dipotassium*	Carbohydrates
D-myo-Inositol 1-monophosphate (dipotassium) is a biochemical reagent .

HY-W790474

*D-myo-Inositol 1,3,4-tris-phosphate*	Carbohydrates
D-myo-Inositol 1,3,4-tris-phosphate is a biochemical assay reagent.

HY-W741523

*1,2:4,5-Di-O-cyclohexylidene-D-myo-inositol*	Carbohydrates
1,2:4,5-Di-O-cyclohexylidene-D-myo-inositol is a biochemical assay reagent.

HY-167241

*D-myo-Inositol,1,5,6-tris(dihydrogen phosphate),ammonium salt*	Carbohydrates
D-myo-Inositol,1,5,6-tris(dihydrogen phosphate),ammonium salt is a biochemical reagent.

HY-W145699

D-myo-Inositol 4-monophosphate

Biochemical Assay Reagents

D-myo-Inositol 4-mono-phosphate, also known as IMP, is a phosphorylated form of inositol that is commonly found in various metabolic pathways, especially in the biosynthesis of phospholipids and cell signaling molecules. D-myo-Inositol 4-mono-phosphate has unique chemical properties that make it an important intermediate in the production of second messengers, such as inositol triphosphate (IP3) and diacylglycerol (DAG), which signal in cells plays a key role in. D-myo-Inositol 4-mono-phosphate is also used in dietary supplements and pharmaceuticals because of its potential health benefits, including improved insulin sensitivity and cognitive function.

HY-W795960

*D-Myo-inositol 1,4,5-trisphosphate sodium salt*	Cell Assay Reagents
D-Myo-inositol 1,4,5-trisphosphate sodium salt can be used for preconditioning the heart in biological experiments, providing cardioprotective effects.

HY-167815

myo-Inositol hexasulfate hexapotassium	Cell Assay Reagents
Myo-Inositol hexasulfate hexapotassium is a sulfated derivative of inositol that has the activity of mimicking highly sulfated polysaccharides such as heparin, affecting many cell signaling pathways.

HY-157699

1,2-Dioleoyl-sn-glycero-3-phospho-(1'-myo-inositol-5'-phosphate) ammonium

Drug Delivery

1,2-Dioleoyl-sn-glycero-3-phospho-(1'-myo-inositol-5'-phosphate) ammonium is a membrane-bound signaling molecule with intracellular activity in regulating membrane trafficking and signal transduction. 1,2-Dioleoyl-sn-glycero-3-phospho-(1'-myo-inositol-5'-phosphate) ammonium can be used in the preparation of liposomes to enhance the efficiency of compound delivery. 1,2-Dioleoyl-sn-glycero-3-phospho-(1'-myo-inositol-5'-phosphate) ammonium can also act as a coordinator of the actin cytoskeleton and participate in the regulation of cell morphology and motility.

HY-163966R

Decarboxyl ofloxacin (Standard)	Chelators
Decarboxyl ofloxacin (Standard) is the analytical standard of Decarboxyl ofloxacin. This product is intended for research and analytical applications. (±)-myo-Inositol-1-phosphate is a biochemical assay reagent.

HY-W706729

myo-Inositol 1,3,5-orthoformate	Drug Delivery
myo-Inositol 1,3,5-orthoformate is a biochemical reagent that can be used as a biological material or organic compound for life science related research .

HY-157715

1,2-Dioctanoyl-sn-glycero-3-phospho-(1'-myo-inositol-3',4',5'-trisphosphate) ammonium

Drug Delivery

1,2-Dioctanoyl-sn-glycero-3-phospho-(1'-myo-inositol-3',4',5'-trisphosphate) ammonium is a membrane-bound signaling molecule with activities that regulate cell growth, metabolism, proliferation, and survival. 1,2-Dioctanoyl-sn-glycero-3-phospho-(1'-myo-inositol-3',4',5'-trisphosphate) ammonium plays an important role in cell physiology and participates in multiple signal transduction pathways. 1,2-Dioctanoyl-sn-glycero-3-phospho-(1'-myo-inositol-3',4',5'-trisphosphate) ammonium has a profound effect on intracellular signaling.

HY-139406

*1,2-Dioctanoyl-sn-glycero-3-phospho-(1'-myo-inositol-4'-phosphate) ammonium* PtdIns-(4)-P1 (1,2-dioctanoyl) ammonium; 08:0 PI(4)P ammonium	Cell Assay Reagents
1,2-Dioctanoyl-sn-glycero-3-phospho-(1'-myo-inositol-4'-phosphate) (PtdIns-(4)-P1 (1,2-dioctanoyl)) ammonium is a synthetic phosphatidylinositol. 1,2-Dioctanoyl-sn-glycero-3-phospho-(1'-myo-inositol-4'-phosphate) ammonium can be used for the research of signal transduction research .

HY-170424

*D-myo-Inositol-1,3,4,5-tetrakisphosphate potassium*	Drug Delivery
D-myo-Inositol-1,3,4,5-tetrakisphosphate potassium increases the extracellular Ca ²⁺ entry through upregulation of voltage-gated calcium channels .

HY-157651

*1-Stearoyl-2-arachidonoyl-sn-glycero-3-phospho-(1'-myo-inositol-3',4'-bisphosphate) ammonium*	Drug Delivery
1-Stearoyl-2-arachidonoyl-sn-glycero-3-phospho-(1'-myo-inositol-3',4'-bisphosphate) ammonium 可调节与内吞结构相关的肌动蛋白网的活性。

HY-157714

08:0 PI(3,4)P2 1,2-Dioctanoyl-sn-glycero-3-phospho-1′-myo-inositol-3′,4′-bisphosphate (ammonium)	Drug Delivery
08:0 PI(3,4)P2 (1,2-Dioctanoyl-sn-glycero-3-phospho-(1′-myo-inositol-3′,4′-bisphosphate) (ammonium)) is a kind of biochemical reagent.

HY-157703

18:1 PI(4,5)P2 1,2-Dioleoyl-sn-glycero-3-phospho-1′-myo-inositol-4′,5′-bisphosphate (ammonium)	Drug Delivery
18:1 PI(4,5)P2 (1,2-Dioleoyl-sn-glycero-3-phospho-(1′-myo-inositol-4′,5′-bisphosphate) (ammonium)) is a kind of biochemical reagent.

HY-W331816

myo-Inositol,hexaacetate

Carbohydrates

myo-Inositol,hexaacetate is a class of biochemical reagents used in glycobiology research. Glycobiology studies the structure, synthesis, biology, and evolution of sugars. It involves carbohydrate chemistry, enzymology of glycan formation and degradation, protein-glycan recognition, and the role of glycans in biological systems. This field is closely related to basic research, biomedicine, and biotechnology .

HY-W151168

1,2-O-Cyclohexylidene-myo-inositol

Carbohydrates

1,2-O-Cyclohexylidene-myo-inositol is a class of biochemical reagents used in glycobiology research. Glycobiology studies the structure, synthesis, biology, and evolution of sugars. It involves carbohydrate chemistry, enzymology of glycan formation and degradation, protein-glycan recognition, and the role of glycans in biological systems. This field is closely related to basic research, biomedicine, and biotechnology .

HY-157652

18:0-20:4 PI(3,4,5)P3 1-Stearoyl-2-arachidonoyl-sn-glycero-3-phospho-1′-myo-inositol-3′,4′,5′-trisphosphate (ammonium)	Drug Delivery
18:0-20:4 PI(3,4,5)P3 (1-Stearoyl-2-arachidonoyl-sn-glycero-3-phospho-(1′-myo-inositol-3′,4′,5′-trisphosphate) (ammonium)) is a kind of biochemical reagent.

HY-W739692

1,2:4,5-Di-O-cyclohexylidene-myo-inositol

Carbohydrates

1,2:4,5-Di-O-cyclohexylidene-myo-inositol is a class of biochemical reagents used in glycobiology research. Glycobiology studies the structure, synthesis, biology, and evolution of sugars. It involves carbohydrate chemistry, enzymology of glycan formation and degradation, protein-glycan recognition, and the role of glycans in biological systems. This field is closely related to basic research, biomedicine, and biotechnology .

HY-W788039

D-Myo-inositol-1,3,5-triphosphate ammonium

Carbohydrates

D-Myo-inositol-1,3,5-triphosphate (ammonium) is a class of biochemical reagents used in glycobiology research. Glycobiology studies the structure, synthesis, biology, and evolution of sugars. It involves carbohydrate chemistry, enzymology of glycan formation and degradation, protein-glycan recognition, and the role of glycans in biological systems. This field is closely related to basic research, biomedicine, and biotechnology .

HY-W567260

1,2:4,5-Bis-O-(1-methylethylidene)-myo-inositol

Carbohydrates

1,2:4,5-Bis-O-(1-methylethylidene)-myo-inositol is a class of biochemical reagents used in glycobiology research. Glycobiology studies the structure, synthesis, biology, and evolution of sugars. It involves carbohydrate chemistry, enzymology of glycan formation and degradation, protein-glycan recognition, and the role of glycans in biological systems. This field is closely related to basic research, biomedicine, and biotechnology .

Cat. No.	Product Name	Target	Research Area

HY-P99588

Stamulumab MYO-029	TGF-β Receptor	Metabolic Disease
Stamulumab (MYO-029) is a recombinant human IgG1λ antibody that binds to myostatin and neutralizes its activity by preventing binding to its endogenous high-affinity receptor ActRIIB. Stamulumab leads to muscle fiber hypertrophy and not hyperplasia in SCID mice. Stamulumab has the potential for Becker muscular dystrophy (BMD), facioscapulohumeral dystrophy (FSHD), and limb-girdle muscular dystrophy (LGMD) research .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-N2421

Sequoyitol 1 Publications Verification 5-O-Methyl-myo-inositol	Natural Products Classification of Application Fields Leguminosae Glycine max (L.) merr Source classification Metabolic Disease Plants Disease Research Fields	Others
Sequoyitol (5-O-Methyl-myo-inositol) is isolated from plants. Sequoyitol (5-O-Methyl-myo-inositol) decreases blood glucose, improves glucose intolerance, and is used to treat diabetes .

HY-B1411

i-Inositol 2 Publications Verification myo-Inositol; meso-Inositol	Structural Classification Natural Products Classification of Application Fields Anti-aging Source classification Endocrine diseases Endogenous metabolite Human Gut Microbiota Metabolites Immune System Disorder Microorganisms Disease markers Other Diseases Disease Research Fields	Endogenous Metabolite
i-Inositol (myo-Inositol) is a compound of sugar alcohols. i-Inositol is involved in a series of biological processes such as insulin signal transduction and cytoskeletal transduction. i-Inositol mainly exists in glial cells and plays an osmotic role .

HY-B1411R

i-Inositol (Standard) myo-Inositol (Standard); meso-Inositol (Standard)	Structural Classification Natural Products Human Gut Microbiota Metabolites Immune System Disorder Microorganisms Source classification Disease markers Endocrine diseases Endogenous metabolite	Reference Standards Endogenous Metabolite
i-Inositol (Standard) is the analytical standard of i-Inositol. This product is intended for research and analytical applications. i-Inositol (myo-Inositol) is a compound of sugar alcohols. i-Inositol is involved in a series of biological processes such as insulin signal transduction and cytoskeletal transduction. i-Inositol mainly exists in glial cells and plays an osmotic role .

HY-N2581

Phytic acid sodium salt 1 Publications Verification myo-Inositol, hexakis(dihydrogen phosphate) sodium salt; Inositol hexaphosphate sodium salt	Structural Classification Natural Products Zea mays L. Classification of Application Fields Gramineae Source classification Other Diseases Plants Disease Research Fields	Endogenous Metabolite Amyloid-β Autophagy
Phytic acid sodium salt (myo-Inositol; hexakis dihydrogen phosphate; Inositol hexaphosphate) is an orally active compound derived from the seeds of legumes. Phytic acid sodium salt is a [PO4] ³- storage depot and precursor for other inositol phosphates and pyrophosphates. phytic acid is hydrolyzed by phytases in a stepwise manner in the plant. Phytic acid sodium salt attenuates Aβ oligomers and upregulates autophagy protein. Phytic acid sodium salt can be used in cardiovascular disease, metabolic disease, nervous system disease and cancer research .

HY-W145699

*D-myo-Inositol 4-monophosphate*	Structural Classification Natural Products Classification of Application Fields Source classification Other Diseases Endogenous metabolite Disease Research Fields	Biochemical Assay Reagents Endogenous Metabolite
D-myo-Inositol 4-mono-phosphate, also known as IMP, is a phosphorylated form of inositol that is commonly found in various metabolic pathways, especially in the biosynthesis of phospholipids and cell signaling molecules. D-myo-Inositol 4-mono-phosphate has unique chemical properties that make it an important intermediate in the production of second messengers, such as inositol triphosphate (IP3) and diacylglycerol (DAG), which signal in cells plays a key role in. D-myo-Inositol 4-mono-phosphate is also used in dietary supplements and pharmaceuticals because of its potential health benefits, including improved insulin sensitivity and cognitive function.

HY-N15179

Minosaminomycin	Structural Classification Microorganisms Antibiotics Source classification	Antibiotic Bacterial
Minosaminomycin is an antibiotic containing myo-inosamine that can be extracted from Streptomyces No. MA514A1. Minosaminomycin exerts antimicrobial activity against Mycobacterium smegrnatis ATCC 607 and Mycobacterium phlei (MIC= 1.56/6.25 mcg/mL) .

HY-N2581R

Phytic acid sodium salt (Standard) myo-Inositol, hexakis(dihydrogen phosphate) sodium salt (Standard); Inositol hexaphosphate sodium salt (Standard)	Structural Classification Natural Products Zea mays L. Gramineae Source classification Plants	Reference Standards Endogenous Metabolite
Phytic acid (sodium salt) (Standard) is the analytical standard of Phytic acid (sodium salt). This product is intended for research and analytical applications. Phytic acid sodium salt (myo-Inositol; hexakis dihydrogen phosphate; Inositol hexaphosphat) is often present in legume seeds with antinutritional effects. Phytic acid sodium salt is a [PO4]3- storage depot and precursor for other inositol phosphates and pyrophosphates. phytic acid is hydrolyzed by phytases in a stepwise manner in the plant .

Cat. No.	Product Name	Chemical Structure

HY-146949S

*D-Myo-phosphatidylinositol diC16-d5*
D-Myo-phosphatidylinositol diC16-d₅ is deuterium labeled D-Myo-phosphatidylinositol diC16.

HY-146947S

*D-Myo-phosphatidylinositol 4-phosphate diC16-d5*
D-Myo-phosphatidylinositol 4-phosphate diC16-d₅ is deuterium labeled D-Myo-phosphatidylinositol 4-phosphate diC16.

HY-146948S

*D-Myo-phosphatidylinositol 4,5-bisphosphate diC16-d5*
D-Myo-phosphatidylinositol 4,5-bisphosphate diC16-d₅ is deuterium labeled D-Myo-phosphatidylinositol 4,5-bisphosphate diC16.

HY-146946S

*D-Myo-phosphatidylinositol 3,4,5-trisphosphate diC16-d5*
D-Myo-phosphatidylinositol 3,4,5-trisphosphate diC16-d₅ is deuterium labeled D-Myo-phosphatidylinositol 3,4,5-trisphosphate diC16.

HY-146872S

*D-myo-Inositol, 1-[(2R)-2-hydroxy-3-[(1-oxoheptadecyl)oxy]propyl-1,1,2,3,3-d5 hydrogen phosphate], ammonium salt (1:1)*
D-myo-Inositol, 1-[(2R)-2-hydroxy-3-[(1-oxoheptadecyl)oxy]propyl-1,1,2,3,3-d₅ hydrogen phosphate], ammonium salt (1:1) is deuterium labeled D-myo-Inositol, 1-[(2R)-2-hydroxy-3-[(1-oxoheptadecyl)oxy]propyl-1,1,2,3,3 hydrogen phosphate], ammonium salt (1:1)

HY-146862S

*D-myo-Inositol, 1-[(2R)-2-hydroxy-3-[(1-oxononadecyl)oxy]propyl-1,1,2,3,3-d5 hydrogen phosphate], ammonium salt (1:1)*
D-myo-Inositol, 1-[(2R)-2-hydroxy-3-[(1-oxononadecyl)oxy]propyl-1,1,2,3,3-d₅ hydrogen phosphate], ammonium salt (1:1) is deuterium labeled D-myo-Inositol, 1-[(2R)-2-hydroxy-3-[(1-oxononadecyl)oxy]propyl-1,1,2,3,3 hydrogen phosphate], ammonium salt (1:1).

HY-146871S

*D-myo-Inositol, 1-[(2R)-2-hydroxy-3-[(1-oxopentadecyl)oxy]propyl-1,1,2,3,3-d5 hydrogen phosphate], ammonium salt (1:1)*
D-myo-Inositol, 1-[(2R)-2-hydroxy-3-[(1-oxopentadecyl)oxy]propyl-1,1,2,3,3-d₅ hydrogen phosphate], ammonium salt (1:1) is deuterium labeled D-myo-Inositol, 1-[(2R)-2-hydroxy-3-[(1-oxopentadecyl)oxy]propyl-1,1,2,3,3 hydrogen phosphate], ammonium salt (1:1)

HY-146874S

*D-myo-Inositol, 1-[(2R)-3-[(1-oxoheptadecyl)oxy]-2-[[(9Z)-1-oxo-9-hexadecen-1-yl]oxy]propyl hydrogen phosphate], ammonium salt (1:1)*
D-myo-Inositol, 1-[(2R)-3-[(1-oxoheptadecyl)oxy]-2-[[(9Z)-1-oxo-9-hexadecen-1-yl]oxy]propyl hydrogen phosphate]-d₅, ammonium salt (1:1) is an isotopically labeled compound.

HY-146873S

*D-myo-Inositol, 1-[(2R)-3-[(1-oxoheptadecyl)oxy]-2-[[(9Z)-1-oxo-9-tetradecen-1-yl]oxy]propyl hydrogen phosphate], ammonium salt (1:1)*
D-myo-Inositol, 1-[(2R)-3-[(1-oxoheptadecyl)oxy]-2-[[(9Z)-1-oxo-9-tetradecen-1-yl]oxy]propyl hydrogen phosphate]-d₅, ammonium salt (1:1) is an isotopically labeled compound.

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

MYOS

Inhibitors & Agonists

Biochemical Assay Reagents

Inhibitory Antibodies

NaturalProducts

Isotope-Labeled Compounds

Oligonucleotides

Natural
Products